Alan Farrell
Question:773. Deputy Alan Farrell asked the Minister for Health his policy regarding the addition of the meningitis vaccination to the national vaccination programme; and if he will make a statement on the matter. [5182/13]
View answerDáil Éireann Debate, Tuesday - 5 February 2013
773. Deputy Alan Farrell asked the Minister for Health his policy regarding the addition of the meningitis vaccination to the national vaccination programme; and if he will make a statement on the matter. [5182/13]
View answer785. Deputy Brendan Griffin asked the Minister for Health if he will introduce the new Meningitis B vaccine into the childhood immunisation schedule (details supplied); and if he will make a statement on the matter. [5241/13]
View answer841. Deputy Thomas Pringle asked the Minister for Health his plans to introduce the new Meningitis B vaccine for Meningococcal B Meningitis and septicaemia into the childhood immunisation schedule; and if he will make a statement on the matter. [5647/13]
View answerI propose to take Questions Nos. 773, 785 and 841 together.
The immunisation programme in Ireland is based on the advice of the National Immunisation Advisory Committee (NIAC). NIAC is a committee of the Royal College of Physicians of Ireland comprising of experts in a number of specialties including infectious diseases, paediatrics and public health. The committee's recommendations are informed by public health advice, international best practice and by the National Centre for Pharmacoeconomics (NCPE).
A Health Technology Assessment which includes a cost benefit analysis is carried out prior to any new vaccine being considered. This has a vital role in ensuring that care technologies, including vaccines, are used in a manner appropriate to their ability to maximise health gain and achieve value for money.
Should NIAC advice recommend the inclusion of a new vaccine into the primary childhood immunisation programme in Ireland, my Department, in association with the Health Service Executive's National Immunisation Office will examine the issue.